Solmeron, Adelai9da D.
HRN: 25-01-32 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/29/2025
09/04/2025
IV
600mg
Q8h
Infected Wound
Checking Initial Appropriateness
08/29/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/29/2025
09/04/2025
IV
1.5g
Q6h
Infected Wound
Checking Initial Appropriateness
09/06/2025
CO-AMOXICLAV 625MG (TAB)
09/06/2025
09/12/2025
ORAL
625mg
BID
Infected Wound
Checking Initial Appropriateness